Education
About Us
Working with TipRanks
Follow Us
Aarey Drugs & Pharmaceuticals Ltd. (IN:AAREYDRUGS)
:AAREYDRUGS
Total Valuation
Aarey Drugs & Pharmaceuticals Ltd. has a market cap or net worth of ₹1.69B. The enterprise value is ₹1.17B.
Market Cap₹1.69B
Enterprise Value₹1.17B
Share Statistics
Aarey Drugs & Pharmaceuticals Ltd. has 28,354,303 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,354,303
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarey Drugs & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 0.12%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)0.12%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.99
Inventory Turnover10.22
Valuation Ratios
The current PE Ratio of Aarey Drugs & Pharmaceuticals Ltd. is 0.00. Aarey Drugs & Pharmaceuticals Ltd.’s PEG ratio is 2.56.
PE Ratio0.00
PS Ratio0.00
PB Ratio1.17
Price to Fair Value0.00
Price to FCF-187.94
Price to Operating Cash Flow147.19
PEG Ratio2.56
Income Statement
In the last 12 months, Aarey Drugs & Pharmaceuticals Ltd. had revenue of 4.74B and earned 40.24M in profits. Earnings per share was 1.43.
Revenue4.74B
Gross Profit91.32M
Operating Income3.06M
Pretax Income61.02M
Net Income40.24M
EBITDA120.64M
Earnings Per Share (EPS)1.43
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Aarey Drugs & Pharmaceuticals Ltd. pays an annual dividend of ₹0.1, resulting in a dividend yield of ―
Dividend Per Share₹0.1
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.87
52-Week Price Change25.05%
50-Day Moving Average54.66
200-Day Moving Average54.87
Relative Strength Index (RSI)68.96
Average Volume (3m)7.02K
Important Dates
Aarey Drugs & Pharmaceuticals Ltd. upcoming earnings date is Aug 13, 2025, TBA (Confirmed).
Last Earnings DateMay 30, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend DateDec 13, 2018
Financial Position
Aarey Drugs & Pharmaceuticals Ltd. as a current ratio of 2.20, with Debt / Equity ratio of 18.66%
Current Ratio2.20
Quick Ratio1.73
Debt to Market Cap0.00
Net Debt to EBITDA2.77
Interest Coverage Ratio0.08
Taxes
In the past 12 months, Aarey Drugs & Pharmaceuticals Ltd. has paid 20.78M in taxes.
Income Tax20.78M
Effective Tax Rate0.34
Enterprise Valuation
Aarey Drugs & Pharmaceuticals Ltd. EV to EBITDA ratio is 2.77, with an EV/FCF ratio of -7.75.
EV to Sales0.07
EV to EBITDA2.77
EV to Free Cash Flow-7.75
EV to Operating Cash Flow37.31
Balance Sheet
Aarey Drugs & Pharmaceuticals Ltd. has ₹14.90M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹14.90M billion.
Cash & Marketable Securities₹14.90M
Total Debt₹0.00
Net Cash-₹14.90M
Net Cash Per Share-₹0.53
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 3.87%, with operating margin of 0.06%, and net profit margin of 0.85%.
Gross Margin3.87%
Operating Margin0.06%
Pretax Margin1.29%
Net Profit Margin0.85%
EBITDA Margin2.55%
EBIT Margin2.14%
Analyst Forecast
The average price target for Aarey Drugs & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―